People | December 06, 2022
Biocon Biologics elevates Shreehas Tambe as MD & CEO
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
With this QIP placement, the Dhanuka group, which took over the company in 2018, is also meeting its mandatory obligation to dilute 15 percent stake in the company by March 2023
Approval broadens indication for ENHERTU to earlier use in metastatic breast cancer and requirement for confirmatory phase 3 trial
In fact, the overall CPHI Pharma Index – a collateralised metric of all major ranking categories – has risen by more than 8%, the largest year-on-year gain in the survey’s six year history
The company is focussed on increasing the capacity utilizations while controlling costs
The dividend cheque of Rs. 9.93 crore for the Ministry of Ayush was handed over to Sonowal
Pantoprazole Sodium Sesquihydrate are proton pump inhibitors used in drugs to suppress the gastric acid secretion
API platform to comprise of RA Chem Pharma, ZCL Chemicals and Avra Laboratories
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
Indigenously-developed molecular diagnostics have helped expand the reach of diagnosis to every part of the country today
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
